Regional delivery of anticancer drugs: current applications.
Where this comes from
- Record sourced from PubMed, PMID 10946454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For cancers that remain confined to a specific region through most of their course, one treatment option is to deliver anticancer drugs directly to that region. Clinical experience shows that regional delivery can palliate symptoms, improve quality of life, and prolong survival. However, whether it increases the cure rate remains controversial, and it is costly because of the need to surgically implant infusion devices.